Author archives: a1095400
Search news stories
Enter a keyword to search news.
SAiGENCI Community Research Partners
The inaugural meeting of SAiGENCI Community Research Partners was held on 14 December.
Listen to Professor Jose Polo on The Stem Cell Podcast
Tune in to Professor Jose Polo, SAiGENCI's Program Lead for Cancer Epigenetics, on The Stem Cell Podcast.
[Read more about Listen to Professor Jose Polo on The Stem Cell Podcast]
2024 David Beale PhD Supplementary Scholarship in Prostate Cancer Research
The David Beale PhD Supplementary Scholarship in Prostate Cancer Research was established in 2023 from a generous donation to the University of Adelaide from David Beale to support outstanding emerging researchers in better understanding the causes and exploring potential treatments and cures for prostate cancer.
[Read more about 2024 David Beale PhD Supplementary Scholarship in Prostate Cancer Research]
Adelaide Summer Research Scholarships with SAiGENCI
The University of Adelaide, Adelaide Summer Research Scholarships have been created to provide undergraduate students with experience working within a research team and to encourage students to consider postgraduate study leading to a career involving research.
[Read more about Adelaide Summer Research Scholarships with SAiGENCI]
SAiGENCI recruit recognised with prestigious award
Professor Jenkins has been appointed as the Program Head for the Tumour Inflammation and Immunotherapy Program at the South Australian ImmunoGENomics Cancer Institute (SAiGENCI), which operates within the University of Adelaide’s Faculty of Health and Medical Sciences, and is supported by an alliance with the Central Adelaide Local Health Network (CALHN).
[Read more about SAiGENCI recruit recognised with prestigious award]
National award recognises leading research into pregnancy complications
Chief Investigator Professor Jose Polo from the University of Adelaide received the 2022 National Health and Medical Research Council’s (NHMRC) Fiona Stanley Synergy Grant Award at an evening ceremony in Canberra on Wednesday 29 March.
[Read more about National award recognises leading research into pregnancy complications ]
ENZAMET shows promise as prostate cancer treatment
The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South Australian immunoGENomics Cancer Institute (SAiGENCI) that operates within the University of Adelaide, have been published today in The Lancet Oncology .
[Read more about ENZAMET shows promise as prostate cancer treatment ]